Cargando…

Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis

OBJECTIVE: Chemokines, which are chemotactic inflammatory mediators involved in controlling the migration and residence of all immune cells, are closely associated with brain inflammation, recognized as one of the potential processes/mechanisms associated with cognitive impairment. We aim to determi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Futao, Sun, Yangyan, Xie, Xinhua, Zhao, Yushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249313/ https://www.ncbi.nlm.nih.gov/pubmed/37291639 http://dx.doi.org/10.1186/s13195-023-01254-1

Ejemplares similares

Blood and CSF Homocysteine Levels in Alzheimer’s Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies
por: Zhang, Ling, et al.
Publicado: (2022)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
por: Ott, Brian R., et al.
Publicado: (2018)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults
por: Sible, Isabel J., et al.
Publicado: (2022)

Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients
por: Berezhnoy, Georgy, et al.
Publicado: (2023)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment
por: Chan, Carol K., et al.
Publicado: (2020)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis
por: Zabala-Findlay, Alex, et al.
Publicado: (2023)

Retinal blood flow in mild cognitive impairment and Alzheimer's disease
por: Feke, Gilbert T., et al.
Publicado: (2015)

Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
por: Cooper, Yonatan A., et al.
Publicado: (2018)

CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment
por: Paolini Paoletti, Federico, et al.
Publicado: (2023)

Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer's disease dementia
por: Contreras, Joey A., et al.
Publicado: (2022)

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Aggressive Behaviors in Alzheimer Disease and Mild Cognitive Impairment: Systematic Review and Meta-Analysis
por: Yu, Rongqin, et al.
Publicado: (2019)

Probiotics for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Zhu, Guangsu, et al.
Publicado: (2021)

Blood levels of circulating methionine components in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
por: Zhao, Yan, et al.
Publicado: (2022)

Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis
por: Chen, Jinghan Jenny, et al.
Publicado: (2022)

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013)

CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment
por: Berlot, Rok, et al.
Publicado: (2014)

Association Analysis of Peripheral and CSF Biomarkers in Late Mild Cognitive Impairment
por: Zhang, Tao, et al.
Publicado: (2020)

Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers
por: Escudero, Javier, et al.
Publicado: (2011)

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
por: Jiang, Hong, et al.
Publicado: (2011)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
por: Palmqvist, Sebastian, et al.
Publicado: (2012)

Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
por: Zou, Ting, et al.
Publicado: (2023)

Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
por: Bottero, Virginie, et al.
Publicado: (2019)

Improving CSF Biomarkers’ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease by Considering Different Confounding Factors: A Meta-Analysis
por: Ferreira, Daniel, et al.
Publicado: (2014)

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
por: de la Monte, Suzanne M., et al.
Publicado: (2023)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
por: Kellar, D., et al.
Publicado: (2021)

Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease
por: Mattsson, Niklas, et al.
Publicado: (2013)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Saccadic Eye Movement in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Opwonya, Julius, et al.
Publicado: (2021)

Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
por: Jemimah, Sherlyn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rga1ea99bk4efueaji6qbdqjop